P6 data is at nine months is not a big dealThe six month data was a big deal. Financially, it works out better for the company if there is a second treatment at six months. Every other procedure has many, many treatments. As you know, the protocol for phase 2 will be to treat at six months regardless if the cancer is present. We may not know until the treatment is commercial how many of the patients needed only one treatment. Phase 2 is the end and could be terminated early and is not doing any single treatments .